Capabilities · Technology transfer & contract manufacturing

Clinical & commercial batch programmes

A proposed service scope for distinct batch execution phases, connecting initial investigational material preparation, scaled production runs and routine supply schedules.

PlannedCatalogue scope

Illustrative unbranded sanitary tri-clamp connection detail.
Illustrative unbranded sanitary tri-clamp connection detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Clinical and commercial batch execution is presented as a planned service domain. The exact product, intended phase, presentation format and technical route would define its scope.

The proposed services catalogue includes this batch execution domain as a broader technical interest. It lies outside the initial project plan and would need formal scope confirmation.

Clinical supply and commercial production are distinct technical subjects subject to different regulatory frameworks. Inclusion in a common catalogue does not establish that one pathway applies universally.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Investigational product batchesEarly phase material preparation intended for controlled clinical investigation.Catalogue scopePlanned
Registration and validation batchesProduction runs required to support process qualification and regulatory submissions.Catalogue scopePlanned
Commercial supply batchesRoutine production schedules subject to marketing authorisations and lifecycle controls.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Programme scope definition

Identify the intended clinical or commercial phase, presentation format and the applicable regulatory pathway.

02 · Process stage

Planned

Material supply coordination

Consider active pharmaceutical ingredient availability, excipient sourcing and packaging component procurement requirements.

03 · Process stage

Planned

Batch execution planning

Map proposed production schedules, equipment allocation and necessary unit operations for the intended campaign.

04 · Process stage

Planned

In-process control integration

Define the required sampling points, analytical methods and acceptance criteria throughout the production steps.

05 · Process stage

Planned

Documentation and record compilation

Generate the batch manufacturing records, analytical reports and associated quality documentation for technical review.

06 · Process stage

Planned

Review and disposition framework

Establish the sequence for data evaluation, deviation assessment and the final batch disposition decision.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Contract manufacturing

Future product-specific manufacturing arrangements, subject to readiness and permissions.

Explore proposed scope

02PlannedCatalogue scope

Technology transfer

Product knowledge, process information and responsibilities for a proposed transfer.

Explore proposed scope

03PlannedCatalogue scope

Regulatory dossier support

Product-specific document structures and evidence requirements.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Product and phase definition
Exact formulation, presentation format and the intended clinical or commercial application.
Facility and systems
Relevant installed systems, qualification status and an approved scope of operations.
Process evidence
Defined parameters, appropriate validation data and the required contamination control strategy.
Quality responsibilities
Controlled records, analytical scope, review procedures and formal decision rights.
Regulatory context
Applicable facility permissions and relevant clinical trial or marketing authorisations.
Technical agreement
Responsibilities, disclosure requirements and technical boundaries for any future engagement.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating clinical or commercial batch programme.

Which production scales are in scope?

The exact scales depend on the product type, presentation format and phase of development. All such parameters would require separate technical evaluation and formal scope confirmation.

What information helps define the question?

Identify the proposed product, presentation, development stage, intended destination and the batch execution question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, scope, permissions, evidence and any commercial agreement would need to be established before a service or supply commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma